Literature DB >> 20012562

Notch1 expression correlates with tumor differentiation status in ovarian carcinoma.

Mingyi Wang1, Jian Wang, Lin Wang, Liying Wu, Xiaoyan Xin.   

Abstract

Notch signaling and its receptor Notch1 are expressed in ovarian epithelial tumors, but the relationship between Notch signaling and ovarian cancer remains to be elucidated. In this study, we detected the expression of Notch1 in ovarian tissues and human ovarian cancer cell lines. We also analyzed the expression of Notch1 and its relationship with differentiation status and FIGO (Federation International of Gynecology and Obstetrics) stage in ovarian cancer tissues. Immunohistochemistry, real-time polymerase chain reaction and Western blot were used to detect the expression of Notch1 in 109 ovarian cancer tissues, 65 patient-matched opposite side normal ovarian tissues and 48 normal ovarian tissues, together with A2780, HO-8910 and IOSE 144 cell lines. Our results showed that the expression of Notch1 in ovarian cancer tissues was higher than that in matched normal tissues and normal tissues, Notch1 is highly expressed in ovarian cancer cells A2780 and HO-8910. Moreover, expression of Notch1 increased gradually with the poor differentiating of cancer tissues and the increasing of FIGO stage in ovarian cancer tissues. It was concluded that Notch1 might be involved and play an oncogenic role in the development of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20012562     DOI: 10.1007/s12032-009-9384-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  17 in total

Review 1.  Notch signaling: cell fate control and signal integration in development.

Authors:  S Artavanis-Tsakonas; M D Rand; R J Lake
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

Review 2.  Ovarian cancer screening: are we making any progress?

Authors:  P J Paley
Journal:  Curr Opin Oncol       Date:  2001-09       Impact factor: 3.645

Review 3.  Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling.

Authors:  Mark E Fortini
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

Review 4.  Notch signaling: the demise of elegant simplicity.

Authors:  Tom Kadesch
Journal:  Curr Opin Genet Dev       Date:  2004-10       Impact factor: 5.578

Review 5.  Notch signaling.

Authors:  Lucio Miele
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

Review 6.  Ovarian cancer: epidemiology, biology, and prognostic factors.

Authors:  C H Holschneider; J S Berek
Journal:  Semin Surg Oncol       Date:  2000 Jul-Aug

7.  Blocking Notch1 signaling by RNA interference can induce growth inhibition in HeLa cells.

Authors:  H Yu; X Zhao; S Huang; L Jian; G Qian; S Ge
Journal:  Int J Gynecol Cancer       Date:  2007-02-02       Impact factor: 3.437

8.  c-myc over-expression in human primary ovarian tumours: its relevance to tumour progression.

Authors:  H Tashiro; K Miyazaki; H Okamura; A Iwai; M Fukumoto
Journal:  Int J Cancer       Date:  1992-03-12       Impact factor: 7.396

9.  K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.

Authors:  T Enomoto; C M Weghorst; M Inoue; O Tanizawa; J M Rice
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

10.  The Notch pathway in ovarian carcinomas and adenomas.

Authors:  O Hopfer; D Zwahlen; M F Fey; S Aebi
Journal:  Br J Cancer       Date:  2005-09-19       Impact factor: 7.640

View more
  19 in total

1.  Targeting of Lung Cancer Stem Cell Self-Renewal Pathway by a Small Molecule Verrucarin J.

Authors:  Karen Udoh; Seema Parte; Kelsey Carter; Aaron Mack; Sham S Kakar
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

2.  The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance.

Authors:  Luyao Liu; Zhu-Lin Yang; Chunwei Wang; Xiongying Miao; Zhiyu Liu; Daiqiang Li; Qiong Zou; Jinghe Li; Lufeng Liang; Guixiang Zeng; Senlin Chen
Journal:  Pathol Oncol Res       Date:  2015-12-03       Impact factor: 3.201

Review 3.  Therapeutic advances in women's cancers.

Authors:  Amy R Carroll; Robert L Coleman; Anil K Sood
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

4.  CIAPIN1 nuclear accumulation predicts poor clinical outcome in epithelial ovarian cancer.

Authors:  Xiaolan Cai; Jian Wang; Xiaoyan Xin
Journal:  World J Surg Oncol       Date:  2012-06-19       Impact factor: 2.754

5.  The translation factor eIF6 is a Notch-dependent regulator of cell migration and invasion.

Authors:  Dario Benelli; Samantha Cialfi; Michela Pinzaglia; Claudio Talora; Paola Londei
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

6.  High-level expression of Notch1 increased the risk of metastasis in T1 stage clear cell renal cell carcinoma.

Authors:  Qing Ai; Xin Ma; Qingbo Huang; Shangwen Liu; Taoping Shi; Chao Zhang; Mingyang Zhu; Yu Zhang; Baojun Wang; Dong Ni; Hongzhao Li; Tao Zheng; Xu Zhang
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

Review 7.  Notch signaling in serous ovarian cancer.

Authors:  Jolijn W Groeneweg; Rosemary Foster; Whitfield B Growdon; René H M Verheijen; Bo R Rueda
Journal:  J Ovarian Res       Date:  2014-11-04       Impact factor: 4.234

8. 

Authors:  Nadežda Lachej; Daiva Dabkevičienė; Aušra Sasnauskienė; Rūta Marija Trimonytė; Daiva Kanopienė; Birutė Kazbarienė; Janina Didžiapetrienė
Journal:  Acta Med Litu       Date:  2017

9.  Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growth.

Authors:  Jolijn W Groeneweg; Celeste M DiGloria; Jing Yuan; William S Richardson; Whitfield B Growdon; Sriram Sathyanarayanan; Rosemary Foster; Bo R Rueda
Journal:  Front Oncol       Date:  2014-07-07       Impact factor: 6.244

Review 10.  Notch signalling pathway as an oncogenic factor involved in cancer development.

Authors:  Marlena Brzozowa-Zasada; Adam Piecuch; Anna Dittfeld; Łukasz Mielańczyk; Marek Michalski; Grzegorz Wyrobiec; Marzena Harabin-Słowińska; Józef Kurek; Romuald Wojnicz
Journal:  Contemp Oncol (Pozn)       Date:  2016-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.